Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (PIGH) is an endoplasmic reticulum-associated enzyme component required for the biosynthesis of glycosylphosphatidylinositol (GPI) anchors[1][3][7][8][9]. This subunit is part of the GPI N-acetylglucosaminyl (GlcNAc) transferase complex, which catalyzes the transfer of N-acetylglucosamine (GlcNAc) to phosphatidylinositol (PI), the first step in GPI anchor biosynthesis[1][3][7][8][9]. GPI anchors tether a wide range of proteins—critical for neuronal development, embryogenesis, and immune signaling—to the cell surface. Genetic variants or silencing of PIGH impair GPI anchor formation and surface display of GPI-anchored proteins, leading to neurological, developmental, and immune dysfunction, as well as resistance to some targeted therapies in hematologic malignancies[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (PIGH).